Literature DB >> 17690848

Clinical presentation of CADASIL in an Italian patient with a rare Gly528Cys exon 10 NOTCH3 gene mutation.

M Ragno1, G Cacchiò, G M Fabrizi, M Scarcella, F Silvaggio, T Cavallaro, F Taioli, L Trojano.   

Abstract

CADASIL is an autosomal dominant arteriopathy characterised by diffuse white matter lesions and small subcortical infarcts on neuroimaging and a variable combination of recurrent cerebral ischaemic episodes, cognitive deficits, migraine with aura and psychiatric symptoms. It is caused by mutations in the NOTCH3 gene encoding a NOTCH3 receptor protein. Here, we describe the genetical, clinical, neuropsychological and neuroimaging findings in an Italian CADASIL patient with a rare mutation in exon 10 leading to a Gly528Cys substitution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690848     DOI: 10.1007/s10072-007-0817-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Diagnostic strategies in CADASIL.

Authors:  Saskia A J Lesnik Oberstein
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

2.  CADASIL with a novel mutation in exon 7 of NOTCH3 (C388Y).

Authors:  Chiho Ishida; Ken-ichi Sakajiri; Mitsuhiro Yoshita; Anne Joutel; Florence Cave-Riant; Masahito Yamada
Journal:  Intern Med       Date:  2006-09-15       Impact factor: 1.271

3.  Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene.

Authors:  M Ragno; G M Fabrizi; G Cacchiò; M Scarcella; G Sirocchi; F Selvaggio; F Taioli; M Ferrarini; L Trojano
Journal:  Neurol Sci       Date:  2006-09       Impact factor: 3.307

4.  CADASIL presenting as bipolar disorder.

Authors:  S K Kumar; G Mahr
Journal:  Psychosomatics       Date:  1997 Jul-Aug       Impact factor: 2.386

Review 5.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum.

Authors:  Martin Dichgans
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

Review 6.  The spectrum of mutations for CADASIL diagnosis.

Authors:  A Federico; S Bianchi; M T Dotti
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

7.  Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies.

Authors:  Nils Peters; Christian Opherk; Tanja Bergmann; Mirna Castro; Jürgen Herzog; Martin Dichgans
Journal:  Arch Neurol       Date:  2005-07

8.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

9.  A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials.

Authors:  Nils Peters; Jürgen Herzog; Christian Opherk; Martin Dichgans
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

10.  Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

View more
  2 in total

1.  High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities.

Authors:  S Bianchi; A Rufa; M Ragno; C D'Eramo; F Pescini; L Pantoni; A Cappelli; A Perretti; E Zicari; P Zolo; D Inzitari; M T Dotti; A Federico
Journal:  J Neurol       Date:  2010-02-19       Impact factor: 4.849

2.  First report of a Tunisian CADASIL patient.

Authors:  Michele Ragno; Katia Nardi; Antonio Manca; Manrico Morroni; Luigi Trojano
Journal:  Neurol Sci       Date:  2012-09-06       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.